25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ARX (Aroa) Stock Analysis
Buy, Hold or Sell?

Let's analyze Aroa together

I guess you are interested in Aroa Biosurgery Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Aroa’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Aroa’s Price Targets

I'm going to help you getting a better view of Aroa Biosurgery Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Aroa Biosurgery Ltd

I send you an email if I find something interesting about Aroa Biosurgery Ltd.

1. Quick Overview

1.1. Quick analysis of Aroa (30 sec.)










1.2. What can you expect buying and holding a share of Aroa? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.22
Expected worth in 1 year
A$0.21
How sure are you?
28.9%

+ What do you gain per year?

Total Gains per Share
A$-0.01
Return On Investment
-1.0%

For what price can you sell your share?

Current Price per Share
A$0.67
Expected price per share
A$0.65 - A$0.805
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Aroa (5 min.)




Live pricePrice per Share (EOD)
A$0.67
Intrinsic Value Per Share
A$0.71 - A$0.86
Total Value Per Share
A$0.92 - A$1.08

2.2. Growth of Aroa (5 min.)




Is Aroa growing?

Current yearPrevious yearGrowGrow %
How rich?$50.4m$52.9m-$2.6m-5.2%

How much money is Aroa making?

Current yearPrevious yearGrowGrow %
Making money-$580.3k-$2.1m$1.5m264.7%
Net Profit Margin-4.8%-15.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Aroa (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Aroa?

Welcome investor! Aroa's management wants to use your money to grow the business. In return you get a share of Aroa.

First you should know what it really means to hold a share of Aroa. And how you can make/lose money.

Speculation

The Price per Share of Aroa is A$0.67. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Aroa.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Aroa, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.22. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Aroa.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-0.1%0.00-0.4%-0.01-1.1%0.00-0.5%0.00-0.7%0.00-0.5%
Usd Book Value Change Per Share0.000.1%0.00-0.2%0.00-0.5%0.00-0.2%0.011.0%0.000.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.1%0.00-0.2%0.00-0.5%0.00-0.2%0.011.0%0.000.5%
Usd Price Per Share0.28-0.39-0.52-0.50-0.55-0.41-
Price to Earnings Ratio-70.80--100.94--21.52--39.89--36.73--62.55-
Price-to-Total Gains Ratio373.38-5.63--22.45-103.62-64.67-121.23-
Price to Book Ratio1.94-2.70-3.36-3.25-4.19-16.65-
Price-to-Total Gains Ratio373.38-5.63--22.45-103.62-64.67-121.23-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.445952
Number of shares2242
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.01
Usd Total Gains Per Share0.000.01
Gains per Quarter (2242 shares)-2.4214.93
Gains per Year (2242 shares)-9.6659.70
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-10-2006050
20-19-300119110
30-29-400179170
40-39-500239230
50-48-600299290
60-58-700358350
70-68-800418410
80-77-900478470
90-87-1000537530
100-97-1100597590

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%2.018.00.010.0%2.031.05.05.3%4.031.040.05.3%
Book Value Change Per Share2.02.00.050.0%5.06.01.041.7%7.08.05.035.0%11.013.014.028.9%20.024.031.026.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.038.00.0%0.00.075.00.0%
Total Gains per Share2.02.00.050.0%5.06.01.041.7%7.08.05.035.0%11.013.014.028.9%20.024.031.026.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Aroa Biosurgery Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.001-0.002+242%-0.005+571%-0.002+267%0.010-89%0.005-79%
Book Value Per Share--0.2190.218+0%0.230-5%0.229-4%0.205+7%0.114+92%
Current Ratio--6.6177.576-13%7.544-12%8.214-19%9.213-28%6.517+2%
Debt To Asset Ratio--0.1450.137+6%0.141+3%0.133+9%0.187-23%0.1460%
Debt To Equity Ratio--0.1700.159+7%0.164+3%0.153+11%0.429-61%0.385-56%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--152169754.711209812435.328-27%281534836.530-46%272833056.071-44%315351602.528-52%240108357.178-37%
Eps---0.002-0.004+167%-0.011+626%-0.005+253%-0.007+377%-0.005+218%
Ev To Ebitda Ratio--21.306-2.014+109%-36.406+271%-21.401+200%-25.129+218%-25.129+218%
Ev To Sales Ratio--1.8382.732-33%3.869-52%3.790-51%4.949-63%22682.701-100%
Free Cash Flow Per Share--0.002-0.003+258%-0.011+644%-0.007+464%-0.010+570%-0.009+516%
Free Cash Flow To Equity Per Share--0.001-0.004+497%-0.012+1233%-0.008+877%0.003-68%0.003-63%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%0.868+15%
Intrinsic Value_10Y_max--0.863----------
Intrinsic Value_10Y_min--0.705----------
Intrinsic Value_1Y_max---0.013----------
Intrinsic Value_1Y_min---0.013----------
Intrinsic Value_3Y_max--0.037----------
Intrinsic Value_3Y_min--0.034----------
Intrinsic Value_5Y_max--0.178----------
Intrinsic Value_5Y_min--0.159----------
Market Cap231725535.360+37%146990078.400203840652.840-28%267608407.440-45%260310226.120-44%288477206.232-49%215409916.077-32%
Net Profit Margin---0.011-0.048+319%-0.157+1278%-0.073+545%-0.161+1314%-78.538+689049%
Operating Margin--0.044-0.041+193%-0.164+472%-0.083+289%-0.161+466%-78.618+178403%
Operating Ratio--0.9561.041-8%1.172-18%0.998-4%0.871+10%82.606-99%
Pb Ratio3.058+37%1.9402.699-28%3.360-42%3.250-40%4.188-54%16.651-88%
Pe Ratio-111.621-58%-70.804-100.944+43%-21.521-70%-39.891-44%-36.729-48%-62.551-12%
Price Per Share0.670+37%0.4250.589-28%0.774-45%0.750-43%0.833-49%0.622-32%
Price To Free Cash Flow Ratio81.778+37%51.87428.060+85%-50.003+196%-16.598+132%-14.619+128%-7.694+115%
Price To Total Gains Ratio588.622+37%373.3805.631+6531%-22.447+106%103.618+260%64.674+477%121.228+208%
Quick Ratio--5.1096.768-25%8.988-43%8.664-41%8.375-39%4.468+14%
Return On Assets---0.003-0.010+277%-0.034+1185%-0.016+492%-0.040+1412%-0.096+3512%
Return On Equity---0.003-0.012+271%-0.040+1177%-0.018+487%-0.091+2818%-0.145+4558%
Total Gains Per Share--0.001-0.002+242%-0.005+571%-0.002+267%0.010-89%0.005-79%
Usd Book Value--50443123.22150296760.465+0%52934483.465-5%52972564.733-5%47253630.958+7%26288090.737+92%
Usd Book Value Change Per Share--0.001-0.001+242%-0.004+571%-0.001+267%0.007-89%0.004-79%
Usd Book Value Per Share--0.1460.145+0%0.153-5%0.153-4%0.136+7%0.076+92%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--101284188.735139651156.954-27%187389587.194-46%181597682.121-44%209898026.643-52%159816122.537-37%
Usd Eps---0.001-0.003+167%-0.007+626%-0.004+253%-0.005+377%-0.003+218%
Usd Free Cash Flow--471512.371-745611.942+258%-2564820.050+644%-1578962.779+435%-1664645.367+453%-879638.131+287%
Usd Free Cash Flow Per Share--0.001-0.002+258%-0.007+644%-0.005+464%-0.006+570%-0.006+516%
Usd Free Cash Flow To Equity Per Share--0.001-0.003+497%-0.008+1233%-0.005+877%0.002-68%0.002-63%
Usd Market Cap154236516.336+37%97836596.183135676338.530-28%178120155.992-45%173262486.505-44%192010428.468-49%143376840.141-32%
Usd Price Per Share0.446+37%0.2830.392-28%0.515-45%0.499-43%0.554-49%0.414-32%
Usd Profit---156969.114-580392.717+270%-2116961.267+1249%-969011.985+517%-1900363.246+1111%-1232941.466+685%
Usd Revenue--13773683.45612837494.758+7%13055182.400+6%11957320.572+15%9113693.755+51%5227646.992+163%
Usd Total Gains Per Share--0.001-0.001+242%-0.004+571%-0.001+267%0.007-89%0.004-79%
 EOD+5 -3MRQTTM+25 -12YOY+23 -143Y+23 -145Y+21 -1610Y+25 -13

3.3 Fundamental Score

Let's check the fundamental score of Aroa Biosurgery Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-111.621
Price to Book Ratio (EOD)Between0-13.058
Net Profit Margin (MRQ)Greater than0-0.011
Operating Margin (MRQ)Greater than00.044
Quick Ratio (MRQ)Greater than15.109
Current Ratio (MRQ)Greater than16.617
Debt to Asset Ratio (MRQ)Less than10.145
Debt to Equity Ratio (MRQ)Less than10.170
Return on Equity (MRQ)Greater than0.15-0.003
Return on Assets (MRQ)Greater than0.05-0.003
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Aroa Biosurgery Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.600
Ma 20Greater thanMa 500.661
Ma 50Greater thanMa 1000.627
Ma 100Greater thanMa 2000.561
OpenGreater thanClose0.690
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Aroa Biosurgery Ltd

Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; Myriad Morcells Fine that delivers a bolus of biologically important ECM proteins to help kick start and sustain healing; and Symphony, a combination cellular and tissue product, indicated for the regeneration of functional tissue in complex wounds. The company also develops products for abdominal wall reconstruction, hernia repair, and breast reconstruction in North America and Europe. Aroa Biosurgery Limited was incorporated in 2007 and is headquartered in Auckland, New Zealand.

Fundamental data was last updated by Penke on 2025-09-11 17:09:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Aroa earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Aroa to theΒ Medical Devices industry mean.
  • A Net Profit Margin of -1.1%Β means thatΒ $-0.01 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Aroa Biosurgery Ltd:

  • The MRQ is -1.1%. The company is making a loss. -1
  • The TTM is -4.8%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-1.1%TTM-4.8%+3.6%
TTM-4.8%YOY-15.7%+10.9%
TTM-4.8%5Y-16.1%+11.3%
5Y-16.1%10Y-7,853.8%+7,837.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.1%-10.9%+9.8%
TTM-4.8%-10.1%+5.3%
YOY-15.7%-15.1%-0.6%
3Y-7.3%-13.9%+6.6%
5Y-16.1%-13.0%-3.1%
10Y-7,853.8%-12.2%-7,841.6%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Aroa is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Aroa to theΒ Medical Devices industry mean.
  • -0.3% Return on Assets means thatΒ Aroa generatedΒ $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Aroa Biosurgery Ltd:

  • The MRQ is -0.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.3%TTM-1.0%+0.7%
TTM-1.0%YOY-3.4%+2.4%
TTM-1.0%5Y-4.0%+3.0%
5Y-4.0%10Y-9.6%+5.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.3%-1.7%+1.4%
TTM-1.0%-2.1%+1.1%
YOY-3.4%-3.3%-0.1%
3Y-1.6%-3.1%+1.5%
5Y-4.0%-2.5%-1.5%
10Y-9.6%-3.1%-6.5%
4.3.1.3. Return on Equity

Shows how efficient Aroa is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Aroa to theΒ Medical Devices industry mean.
  • -0.3% Return on Equity means Aroa generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Aroa Biosurgery Ltd:

  • The MRQ is -0.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -1.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.3%TTM-1.2%+0.8%
TTM-1.2%YOY-4.0%+2.8%
TTM-1.2%5Y-9.1%+7.9%
5Y-9.1%10Y-14.5%+5.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.3%-2.0%+1.7%
TTM-1.2%-2.1%+0.9%
YOY-4.0%-4.0%+0.0%
3Y-1.8%-4.4%+2.6%
5Y-9.1%-4.4%-4.7%
10Y-14.5%-5.8%-8.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Aroa Biosurgery Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Aroa is operatingΒ .

  • Measures how much profit Aroa makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Aroa to theΒ Medical Devices industry mean.
  • An Operating Margin of 4.4%Β means the company generated $0.04 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Aroa Biosurgery Ltd:

  • The MRQ is 4.4%. The company is operating less efficient.
  • The TTM is -4.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ4.4%TTM-4.1%+8.5%
TTM-4.1%YOY-16.4%+12.3%
TTM-4.1%5Y-16.1%+12.0%
5Y-16.1%10Y-7,861.8%+7,845.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4%-19.0%+23.4%
TTM-4.1%-13.7%+9.6%
YOY-16.4%-17.0%+0.6%
3Y-8.3%-13.7%+5.4%
5Y-16.1%-11.5%-4.6%
10Y-7,861.8%-16.2%-7,845.6%
4.3.2.2. Operating Ratio

Measures how efficient Aroa is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Medical Devices industry mean).
  • An Operation Ratio of 0.96 means that the operating costs are $0.96 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Aroa Biosurgery Ltd:

  • The MRQ is 0.956. The company is less efficient in keeping operating costs low.
  • The TTM is 1.041. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.956TTM1.041-0.085
TTM1.041YOY1.172-0.132
TTM1.0415Y0.871+0.170
5Y0.87110Y82.606-81.735
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9561.309-0.353
TTM1.0411.308-0.267
YOY1.1721.221-0.049
3Y0.9981.299-0.301
5Y0.8711.314-0.443
10Y82.6061.322+81.284
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Aroa Biosurgery Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Aroa is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Medical Devices industry mean).
  • A Current Ratio of 6.62Β means the company has $6.62 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Aroa Biosurgery Ltd:

  • The MRQ is 6.617. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.576. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.617TTM7.576-0.959
TTM7.576YOY7.544+0.031
TTM7.5765Y9.213-1.637
5Y9.21310Y6.517+2.696
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.6172.474+4.143
TTM7.5762.594+4.982
YOY7.5442.691+4.853
3Y8.2142.885+5.329
5Y9.2133.528+5.685
10Y6.5173.426+3.091
4.4.3.2. Quick Ratio

Measures if Aroa is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Aroa to theΒ Medical Devices industry mean.
  • A Quick Ratio of 5.11Β means the company can pay off $5.11 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Aroa Biosurgery Ltd:

  • The MRQ is 5.109. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.768. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.109TTM6.768-1.660
TTM6.768YOY8.988-2.220
TTM6.7685Y8.375-1.606
5Y8.37510Y4.468+3.906
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.1091.350+3.759
TTM6.7681.553+5.215
YOY8.9881.706+7.282
3Y8.6641.896+6.768
5Y8.3752.225+6.150
10Y4.4682.519+1.949
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Aroa Biosurgery Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of AroaΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Aroa to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.15Β means that Aroa assets areΒ financed with 14.5% credit (debt) and the remaining percentage (100% - 14.5%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Aroa Biosurgery Ltd:

  • The MRQ is 0.145. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.137. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.145TTM0.137+0.008
TTM0.137YOY0.141-0.004
TTM0.1375Y0.187-0.050
5Y0.18710Y0.146+0.042
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1450.408-0.263
TTM0.1370.414-0.277
YOY0.1410.400-0.259
3Y0.1330.397-0.264
5Y0.1870.420-0.233
10Y0.1460.456-0.310
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Aroa is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Aroa to theΒ Medical Devices industry mean.
  • A Debt to Equity ratio of 17.0% means that company has $0.17 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Aroa Biosurgery Ltd:

  • The MRQ is 0.170. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.159. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.170TTM0.159+0.011
TTM0.159YOY0.164-0.005
TTM0.1595Y0.429-0.271
5Y0.42910Y0.385+0.044
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1700.631-0.461
TTM0.1590.646-0.487
YOY0.1640.599-0.435
3Y0.1530.640-0.487
5Y0.4290.649-0.220
10Y0.3850.769-0.384
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Aroa generates.

  • Above 15 is considered overpriced butΒ always compareΒ Aroa to theΒ Medical Devices industry mean.
  • A PE ratio of -70.80 means the investor is paying $-70.80Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Aroa Biosurgery Ltd:

  • The EOD is -111.621. Based on the earnings, the company is expensive. -2
  • The MRQ is -70.804. Based on the earnings, the company is expensive. -2
  • The TTM is -100.944. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-111.621MRQ-70.804-40.817
MRQ-70.804TTM-100.944+30.140
TTM-100.944YOY-21.521-79.424
TTM-100.9445Y-36.729-64.216
5Y-36.72910Y-62.551+25.822
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-111.621-1.102-110.519
MRQ-70.804-1.233-69.571
TTM-100.944-1.359-99.585
YOY-21.521-2.949-18.572
3Y-39.891-1.780-38.111
5Y-36.729-2.182-34.547
10Y-62.551-2.300-60.251
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Aroa Biosurgery Ltd:

  • The EOD is 81.778. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 51.874. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 28.060. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD81.778MRQ51.874+29.904
MRQ51.874TTM28.060+23.814
TTM28.060YOY-50.003+78.062
TTM28.0605Y-14.619+42.679
5Y-14.61910Y-7.694-6.925
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD81.778-1.632+83.410
MRQ51.874-1.908+53.782
TTM28.060-1.813+29.873
YOY-50.003-3.218-46.785
3Y-16.598-2.227-14.371
5Y-14.619-4.197-10.422
10Y-7.694-4.006-3.688
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Aroa is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Medical Devices industry mean).
  • A PB ratio of 1.94 means the investor is paying $1.94Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Aroa Biosurgery Ltd:

  • The EOD is 3.058. Based on the equity, the company is fair priced.
  • The MRQ is 1.940. Based on the equity, the company is underpriced. +1
  • The TTM is 2.699. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.058MRQ1.940+1.118
MRQ1.940TTM2.699-0.759
TTM2.699YOY3.360-0.661
TTM2.6995Y4.188-1.489
5Y4.18810Y16.651-12.463
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD3.0582.270+0.788
MRQ1.9402.126-0.186
TTM2.6992.196+0.503
YOY3.3602.681+0.679
3Y3.2502.683+0.567
5Y4.1883.672+0.516
10Y16.6514.161+12.490
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Aroa Biosurgery Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in NZD. All numbers in thousands.

Summary
Total Assets98,939
Total Liabilities14,347
Total Stockholder Equity84,592
 As reported
Total Liabilities 14,347
Total Stockholder Equity+ 84,592
Total Assets = 98,939

Assets

Total Assets98,939
Total Current Assets61,955
Long-term Assets36,984
Total Current Assets
Cash And Cash Equivalents 7,262
Short-term Investments 12,866
Net Receivables 14,837
Inventory 7,515
Other Current Assets 19,474
Total Current Assets  (as reported)61,955
Total Current Assets  (calculated)61,955
+/- 0
Long-term Assets
Property Plant Equipment 19,544
Goodwill 5,033
Intangible Assets 12,333
Long-term Assets Other 75
Long-term Assets  (as reported)36,984
Long-term Assets  (calculated)36,984
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities9,363
Long-term Liabilities4,984
Total Stockholder Equity84,592
Total Current Liabilities
Short-term Debt 1,017
Accounts payable 1,514
Other Current Liabilities 6,832
Total Current Liabilities  (as reported)9,363
Total Current Liabilities  (calculated)9,363
+/-0
Long-term Liabilities
Long term Debt Total 5,297
Long-term Liabilities  (as reported)4,984
Long-term Liabilities  (calculated)5,297
+/- 313
Total Stockholder Equity
Common Stock133,444
Retained Earnings -58,213
Accumulated Other Comprehensive Income 9,361
Total Stockholder Equity (as reported)84,592
Total Stockholder Equity (calculated)84,592
+/- 0
Other
Capital Stock133,444
Cash and Short Term Investments 20,128
Common Stock Shares Outstanding 342,473
Liabilities and Stockholders Equity 98,939
Net Debt -1,431
Net Invested Capital 84,592
Net Working Capital 52,592
Property Plant and Equipment Gross 31,327
Short Long Term Debt Total 5,831



5.2. Balance Sheets Structured

Currency in NZD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-09-302019-06-302018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-06-302003-12-312003-06-302002-12-312002-06-302001-12-312001-06-302000-12-312000-06-30
> Total Assets 
4,178
13,851
13,160
12,365
12,096
12,121
11,691
15,441
14,536
19,600
19,784
19,784
40,578
40,578
68,888
68,888
89,054
88,533
68,618
68,618
71,603
71,603
58,957
58,957
83,083
83,083
70,381
70,381
5,131
5,131
4,845
4,845
8,075
8,075
13,077
13,077
10,928
10,928
9,682
9,682
9,357
9,357
8,884
8,884
8,406
8,406
7,850
7,850
7,510
7,510
6,762
6,762
6,355
6,355
6,285
6,285
6,515
6,515
5,914
5,914
6,182
6,182
3,291
3,291
2,927
2,927
0
0
44,521
0
76,038
0
73,125
0
108,410
0
104,706
0
102,120
108,685
109,071
103,741
104,801
102,985
101,878
96,517
97,111
98,425
98,939
98,93998,42597,11196,517101,878102,985104,801103,741109,071108,685102,1200104,7060108,410073,125076,038044,521002,9272,9273,2913,2916,1826,1825,9145,9146,5156,5156,2856,2856,3556,3556,7626,7627,5107,5107,8507,8508,4068,4068,8848,8849,3579,3579,6829,68210,92810,92813,07713,0778,0758,0754,8454,8455,1315,13170,38170,38183,08383,08358,95758,95771,60371,60368,61868,61888,53389,05468,88868,88840,57840,57819,78419,78419,60014,53615,44111,69112,12112,09612,36513,16013,8514,178
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
922
922
577
577
851
851
2,363
2,363
1,981
1,981
0
0
17,415
50,883
46,925
48,749
44,753
81,947
78,260
79,879
74,244
81,708
71,884
72,881
73,140
67,455
68,144
64,017
63,329
58,426
58,786
61,633
61,955
61,95561,63358,78658,42663,32964,01768,14467,45573,14072,88171,88481,70874,24479,87978,26081,94744,75348,74946,92550,88317,415001,9811,9812,3632,36385185157757792292200000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
800
800
468
468
740
740
2,260
2,260
1,911
1,911
0
0
3,729
0
17,230
0
32,480
0
43,253
0
5,730
0
10,545
8,898
8,930
3,645
3,682
10,685
10,570
12,420
12,497
7,224
7,262
7,2627,22412,49712,42010,57010,6853,6823,6458,9308,89810,54505,730043,253032,480017,23003,729001,9111,9112,2602,26074074046846880080000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,089
0
20,288
0
1,454
0
20,511
0
47,624
0
33,549
33,947
34,067
28,565
28,857
17,344
17,157
7,576
7,623
12,799
12,866
12,86612,7997,6237,57617,15717,34428,85728,56534,06733,94733,549047,624020,51101,454020,28802,08900000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
11
11
140
49
38
89
84
184
42
112
115
115
95
95
4,240
4,240
41
7
7
7
89
89
44
44
20
20
28
28
63
63
26
26
34
34
98
98
38
38
200
200
310
310
463
463
461
461
455
455
62
62
219
219
4
4
11
11
9
9
11
11
8
8
19
19
9
9
0
0
7,159
6,120
5,644
7,227
6,599
10,549
10,074
17,169
15,958
24,690
21,722
21,188
13,413
24,125
28,085
24,367
24,102
23,907
24,054
31,677
14,837
14,83731,67724,05423,90724,10224,36728,08524,12513,41321,18821,72224,69015,95817,16910,07410,5496,5997,2275,6446,1207,15900991919881111991111442192196262455455461461463463310310200200383898983434262663632828202044448989777414,2404,240959511511511242184848938491401111
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,879
4,081
3,764
3,608
3,312
3,521
3,363
3,981
3,700
5,157
4,537
4,506
4,522
6,418
6,483
7,515
7,430
8,411
8,447
7,476
7,515
7,5157,4768,4478,4117,4307,5156,4836,4184,5224,5064,5375,1573,7003,9813,3633,5213,3123,6083,7644,0813,87900000000000000000000000000000000000000000000000000000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27,106
0
29,113
0
28,372
0
30,150
0
30,462
0
30,235
35,805
35,932
36,286
36,657
38,968
38,549
38,091
38,325
36,792
36,984
36,98436,79238,32538,09138,54938,96836,65736,28635,93235,80530,235030,462030,150028,372029,113027,10600000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
1,225
2,877
4,248
4,844
5,517
6,534
7,441
9,468
11,671
14,184
14,382
14,382
24,767
24,767
44,585
44,585
73,989
73,501
64,670
64,670
58,469
58,469
50,741
50,741
1,296
1,296
1,414
1,414
1,504
1,504
2,701
2,701
3,606
3,606
5,087
5,087
4,694
4,694
4,960
4,960
4,996
4,996
4,988
4,988
5,136
5,136
5,317
5,317
5,527
5,527
5,761
5,761
5,341
5,341
5,393
5,393
5,405
5,405
5,158
5,158
5,158
5,158
928
928
946
946
0
0
8,460
12,761
11,768
12,658
11,620
13,848
13,225
15,356
14,273
16,309
14,348
19,249
19,318
19,529
19,728
20,601
20,380
20,336
20,422
19,442
19,544
19,54419,44220,42220,33620,38020,60119,72819,52919,31819,24914,34816,30914,27315,35613,22513,84811,62012,65811,76812,7618,460009469469289285,1585,1585,1585,1585,4055,4055,3935,3935,3415,3415,7615,7615,5275,5275,3175,3175,1365,1364,9884,9884,9964,9964,9604,9604,6944,6945,0875,0873,6063,6062,7012,7011,5041,5041,4141,4141,2961,29650,74150,74158,46958,46964,67064,67073,50173,98944,58544,58524,76724,76714,38214,38214,18411,6719,4687,4416,5345,5174,8444,2482,8771,225
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,364
0
0
0
5,084
0
0
0
5,147
0
5,156
5,166
5,184
5,104
5,156
5,135
5,080
5,058
5,079
0
5,033
5,03305,0795,0585,0805,1355,1565,1045,1845,1665,15605,1470005,0840005,36400000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
276
276
95
95
34
34
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,622
0
16,772
0
11,511
0
14,794
0
10,903
0
16,822
10,030
11,312
9,731
9,846
9,375
12,986
8,377
8,429
17,275
12,333
12,33317,2758,4298,37712,9869,3759,8469,73111,31210,03016,822010,903014,794011,511016,772016,6220000000000000000003434959527627600000000000000000000000000000000000000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-3,255
0
404
0
157
0
1,978
0
138
0
0
1,360
118
1,923
1,812
3,856
91
4,320
4,385
74
75
75744,3854,320913,8561,8121,9231181,3600013801,978015704040-3,25500000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
1,677
12,043
2,521
2,203
2,328
2,350
2,183
2,584
2,443
4,373
2,713
2,713
8,019
8,019
33,669
33,669
58,260
58,226
58,240
58,240
89,720
89,720
80,334
80,334
105,731
105,731
89,019
89,019
3,454
3,454
4,197
4,197
3,319
3,319
1,647
1,647
1,588
1,588
302
302
355
355
526
526
827
827
870
870
586
586
431
431
444
444
237
237
235
235
210
210
265
265
284
284
198
198
0
0
37,154
0
18,556
0
19,434
0
10,538
0
11,304
0
12,398
13,646
13,695
14,223
14,369
14,947
14,787
12,455
12,532
14,272
14,347
14,34714,27212,53212,45514,78714,94714,36914,22313,69513,64612,398011,304010,538019,434018,556037,154001981982842842652652102102352352372374444444314315865868708708278275265263553553023021,5881,5881,6471,6473,3193,3194,1974,1973,4543,45489,01989,019105,731105,73180,33480,33489,72089,72058,24058,24058,22658,26033,66933,6698,0198,0192,7132,7134,3732,4432,5842,1832,3502,3282,2032,52112,0431,677
   > Total Current Liabilities 
1,660
12,025
2,501
2,203
2,328
1,304
1,258
1,719
1,531
3,156
1,738
1,738
2,851
2,851
4,182
4,182
11,766
11,733
18,190
18,190
50,132
50,132
38,836
38,836
99,205
99,205
85,618
85,618
209
209
605
605
1,772
1,772
1,586
1,586
1,489
1,489
183
183
201
201
332
332
628
628
664
664
331
331
187
187
375
375
170
170
175
175
155
155
205
205
284
284
198
198
0
0
34,105
4,076
3,759
15,292
14,038
5,366
5,125
6,711
6,238
8,913
7,841
7,379
7,405
8,612
8,700
8,822
8,728
6,846
6,888
9,314
9,363
9,3639,3146,8886,8468,7288,8228,7008,6127,4057,3797,8418,9136,2386,7115,1255,36614,03815,2923,7594,07634,105001981982842842052051551551751751701703753751871873313316646646286283323322012011831831,4891,4891,5861,5861,7721,77260560520920985,61885,61899,20599,20538,83638,83650,13250,13218,19018,19011,73311,7664,1824,1822,8512,8511,7381,7383,1561,5311,7191,2581,3042,3282,2032,50112,0251,660
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,844
0
492
0
9,656
0
580
0
547
0
493
521
523
769
776
931
921
837
843
1,012
1,017
1,0171,0128438379219317767695235214930547058009,656049207,84400000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,136
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000009,136000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
564
1,798
1,411
1,118
993
218
292
753
565
757
0
0
2,603
2,603
3,926
3,926
6,829
6,829
3,065
3,065
2,024
2,024
4,681
4,681
725
725
753
753
142
142
572
572
205
205
346
346
142
142
148
148
112
112
297
297
279
279
629
629
135
135
153
153
94
94
135
135
136
136
118
118
164
164
186
186
86
86
0
0
1,163
2,147
1,980
740
679
2,575
2,459
1,333
1,239
3,850
3,387
1,781
1,787
2,724
2,752
1,585
1,568
2,692
2,709
3,107
1,514
1,5143,1072,7092,6921,5681,5852,7522,7241,7871,7813,3873,8501,2391,3332,4592,5756797401,9802,1471,16300868618618616416411811813613613513594941531531351356296292792792972971121121481481421423463462052055725721421427537537257254,6814,6812,0242,0243,0653,0656,8296,8293,9263,9262,6032,603007575657532922189931,1181,4111,798564
       Other Current Liabilities 
77
9,208
71
66
316
67
66
66
66
1,499
838
838
249
249
256
256
951
917
1,385
1,385
6,676
6,676
15,014
15,014
98,480
98,480
82,781
82,781
67
67
33
33
69
69
35
35
72
72
35
35
89
89
35
35
348
348
35
35
197
197
35
35
281
281
35
35
39
39
37
37
41
41
98
98
37
37
0
0
25,099
201
1,286
27
3,703
35
2,086
100
4,451
1,424
3,962
5,077
5,095
5,119
5,170
6,307
6,239
3,316
3,336
5,196
6,832
6,8325,1963,3363,3166,2396,3075,1705,1195,0955,0773,9621,4244,4511002,086353,703271,28620125,09900373798984141373739393535281281353519719735353483483535898935357272353569693333676782,78182,78198,48098,48015,01415,0146,6766,6761,3851,3859179512562562492498388381,4996666666731666719,20877
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,048
0
14,797
0
5,395
0
5,413
0
5,066
0
4,556
6,267
6,289
5,611
5,669
6,125
6,059
5,609
5,644
4,958
4,984
4,9844,9585,6445,6096,0596,1255,6695,6116,2896,2674,55605,06605,41305,395014,79703,04800000000000000000000000000000000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,886
0
5,716
0
5,504
0
5,287
0
5,011
0
6,548
0
0
0
6,431
0
5,966
0
5,297
5,29705,96606,4310006,54805,01105,28705,50405,716015,8860000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
1,046
0
865
912
1,217
975
975
1,168
1,168
12,033
12,033
13,623
13,623
12,714
12,714
39,589
39,589
38,900
38,900
649
649
0
0
11
11
18
18
48
48
61
61
99
99
119
119
155
155
195
195
200
200
206
206
255
255
244
244
69
69
68
68
59
59
55
55
60
60
0
0
0
0
0
0
0
159
159
161
161
164
164
164
164
168
168
0
0
0
0
0
0
0
0
0
0
0000000000168168164164164164161161159159000000060605555595968686969244244255255206206200200195195155155119119999961614848181811110064964938,90038,90039,58939,58912,71412,71413,62313,62312,03312,0331,1681,1689759751,21791286501,04600000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,332
1,332
0
0
0
0
0
0
0
0
000000001,3321,3320000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
2,501
841
9,838
9,410
8,991
9,029
8,805
12,259
12,093
14,505
16,598
16,598
32,218
32,218
34,846
34,846
30,794
31,461
10,378
10,378
0
0
0
0
0
0
0
0
1,677
1,677
649
649
4,757
4,757
11,430
11,430
9,340
9,340
9,380
9,380
9,002
9,002
8,358
8,358
7,579
7,579
6,981
6,981
6,925
6,925
6,331
6,331
5,912
5,912
6,047
6,047
6,280
6,280
5,704
5,704
5,916
5,916
3,007
3,007
2,729
2,729
0
0
7,367
0
57,482
0
53,691
0
97,872
0
93,402
0
89,722
95,039
95,377
89,518
90,433
88,038
87,079
84,062
84,579
84,153
84,592
84,59284,15384,57984,06287,07988,03890,43389,51895,37795,03989,722093,402097,872053,691057,48207,367002,7292,7293,0073,0075,9165,9165,7045,7046,2806,2806,0476,0475,9125,9126,3316,3316,9256,9256,9816,9817,5797,5798,3588,3589,0029,0029,3809,3809,3409,34011,43011,4304,7574,7576496491,6771,6770000000010,37810,37831,46130,79434,84634,84632,21832,21816,59816,59814,50512,09312,2598,8059,0298,9919,4109,8388412,501
   Retained Earnings -58,213-57,911-59,069-58,708-56,984-57,635-53,838-53,294-48,230-48,059-43,584-49,540-47,521-51,128-45,679-47,831-39,238-42,742-34,366-37,264-22,79500-152,865-152,865-152,588-152,588-146,973-146,973-146,652-146,652-146,079-146,07900000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,730
0
2,223
0
3,591
0
4,582
0
5,450
0
4,810
6,458
6,481
7,720
7,799
9,544
9,441
8,670
8,723
9,313
9,361
9,3619,3138,7238,6709,4419,5447,7997,7206,4816,4584,81005,45004,58203,59102,22301,73000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000



5.3. Balance Sheets

Currency in NZD. All numbers in thousands.




5.4. Cash Flows

Currency in AUD. All numbers in thousands.




5.5. Income Statements

Currency in AUD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2025-03-31. Currency in NZD. All numbers in thousands.

Gross Profit (+$)
totalRevenue76,969
Cost of Revenue-10,981
Gross Profit65,98965,989
 
Operating Income (+$)
Gross Profit65,989
Operating Expense-74,117
Operating Income-8,128-8,128
 
Operating Expense (+$)
Research Development8,693
Selling General Administrative60,931
Selling And Marketing Expenses60,931
Operating Expense74,117130,556
 
Net Interest Income (+$)
Interest Income962
Interest Expense-440
Other Finance Cost-1,101
Net Interest Income-578
 
Pretax Income (+$)
Operating Income-8,128
Net Interest Income-578
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-2,953-13,302
EBIT - interestExpense = -2,285
-2,953
-3,025
Interest Expense440
Earnings Before Interest and Taxes (EBIT)-1,846-2,514
Earnings Before Interest and Taxes (EBITDA)2,646
 
After tax Income (+$)
Income Before Tax-2,953
Tax Provision-512
Net Income From Continuing Ops-3,465-3,465
Net Income-3,465
Net Income Applicable To Common Shares-3,813
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses85,097
Total Other Income/Expenses Net5,174578
 

Technical Analysis of Aroa
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Aroa. The general trend of Aroa is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Aroa's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Aroa Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Aroa Biosurgery Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.72 < 0.72 < 0.805.

The bearish price targets are: 0.65 > 0.65 > 0.65.

Know someone who trades $ARX? Share this with them.πŸ‘‡

Aroa Biosurgery Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Aroa Biosurgery Ltd. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Aroa Biosurgery Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Aroa Biosurgery Ltd. The current macd is 0.01852799.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Aroa price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Aroa. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Aroa price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Aroa Biosurgery Ltd Daily Moving Average Convergence/Divergence (MACD) ChartAroa Biosurgery Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Aroa Biosurgery Ltd. The current adx is 22.91.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Aroa shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Aroa Biosurgery Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Aroa Biosurgery Ltd. The current sar is 0.7092.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Aroa Biosurgery Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Aroa Biosurgery Ltd. The current rsi is 54.60. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Aroa Biosurgery Ltd Daily Relative Strength Index (RSI) ChartAroa Biosurgery Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Aroa Biosurgery Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Aroa price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Aroa Biosurgery Ltd Daily Stochastic Oscillator ChartAroa Biosurgery Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Aroa Biosurgery Ltd. The current cci is 55.73.

Aroa Biosurgery Ltd Daily Commodity Channel Index (CCI) ChartAroa Biosurgery Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Aroa Biosurgery Ltd. The current cmo is 1.92641528.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Aroa Biosurgery Ltd Daily Chande Momentum Oscillator (CMO) ChartAroa Biosurgery Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Aroa Biosurgery Ltd. The current willr is -44.44444444.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Aroa is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Aroa Biosurgery Ltd Daily Williams %R ChartAroa Biosurgery Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Aroa Biosurgery Ltd.

Aroa Biosurgery Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Aroa Biosurgery Ltd. The current atr is 0.02467507.

Aroa Biosurgery Ltd Daily Average True Range (ATR) ChartAroa Biosurgery Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Aroa Biosurgery Ltd. The current obv is -8,642,949.

Aroa Biosurgery Ltd Daily On-Balance Volume (OBV) ChartAroa Biosurgery Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Aroa Biosurgery Ltd. The current mfi is 50.72.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Aroa Biosurgery Ltd Daily Money Flow Index (MFI) ChartAroa Biosurgery Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Aroa Biosurgery Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-29STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-07-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-04STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-11MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-09-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

Aroa Biosurgery Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Aroa Biosurgery Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.600
Ma 20Greater thanMa 500.661
Ma 50Greater thanMa 1000.627
Ma 100Greater thanMa 2000.561
OpenGreater thanClose0.690
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Aroa with someone you think should read this too:
  • Are you bullish or bearish on Aroa? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Aroa? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Aroa Biosurgery Ltd

I send you an email if I find something interesting about Aroa Biosurgery Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Aroa Biosurgery Ltd.

Receive notifications about Aroa Biosurgery Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.